Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 12th:Exxon Mobil XOM: This company that explores for and produces crude oil and natural gas has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.Exxon Mobil Corporation Price and Consensus Exxon Mobil Corporation price-consensus-chart | Exxon Mobil Corporation QuoteExxon Mobil’s shares gained 16.5% over the last three month compared with the S&P 500’s growth of 6.8%. The company possesses a Momentum Score of A.Exxon Mobil Corporation Price Exxon Mobil Corporation price | Exxon Mobil Corporation QuoteAlbemarle ALB: This specialty chemicals company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.Albemarle Corporation Price and Consensus Albemarle Corporation price-consensus-chart | Albemarle Corporation QuoteAlbemarle’s shares gained 10.7% over the last three month compared with the S&P 500’s growth of 6.8%. The company possesses a Momentum Score of A.Albemarle Corporation Price Albemarle Corporation price | Albemarle Corporation QuoteSTMicroelectronics STM: This global independent semiconductor company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.STMicroelectronics N.V. Price and Consensus STMicroelectronics N.V. price-consensus-chart | STMicroelectronics N.V. QuoteSTMicroelectronics’ shares gained 20.0% over the last three month compared with the S&P 500’s growth of 6.8%. The company possesses a Momentum Score of A.STMicroelectronics N.V. Price STMicroelectronics N.V. price | STMicroelectronics N.V. QuoteSee the full list of top ranked stocks hereLearn more about the Momentum score and how it is calculated here. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report STMicroelectronics N.V. (STM): Free Stock Analysis Report Exxon Mobil Corporation (XOM): Free Stock Analysis Report Albemarle Corporation (ALB): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research